The Food and Drug Administration (FDA) has approved Tauklarify â„¢ (florquinitau F 18 injection) for positron emission tomography (PET) of the brain in adults with cognitive impairment who are being ...
Secondary stroke prevention faces barriers like fragmented care, driving the need for precision medicine and novel targeted ...
A multi-analyte blood test may help clinicians distinguish true multiple sclerosis relapses from pseudoexacerbations while awaiting MRI results.
Evaluation of US pediatric data confirms no association between early childhood MMR vaccination and autism diagnosis.
Perioperative magnesium sulfate may modestly reduce postoperative pain and opioid use after spinal surgery, though clinical significance is unclear.
Declining systolic blood pressure may serve as an important clinical indicator of concurrent cognitive decline in older women.
Adults with type 2 diabetes that have greater long-term medication adherence experience lower risk for cardiovascular events.
The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.
Hilary L. Colbeth, Ph.D., from the University of California (UC) Davis, and colleagues examined dementia incidence and its risk factors in people older than 90 years as part of the LifeAfter90 study.
A scientific statement from the American Heart Association outlines the potential cardiovascular benefits of moderate coffee consumption.
Women with long COVID experience higher neurologic symptom burden and worse fatigue than men, regardless of hospitalization status.
A history of traumatic brain injury may reduce the diagnostic accuracy of blood biomarkers used to detect Alzheimer disease ...